124691-76-5 Usage
Uses
Used in Pharmaceutical Industry:
5,6-Dichloro-1H-indazole is used as an intermediate in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs with various therapeutic applications.
Used in Agrochemical Development:
In the agrochemical industry, 5,6-dichloro-1H-indazole is utilized as a building block in the creation of new agrochemicals, potentially enhancing crop protection and yield.
Used in Oncology Research:
5,6-Dichloro-1H-indazole is used as a research compound in oncology for its demonstrated inhibitory effects on the growth of certain cancer cells, making it a candidate for further exploration in cancer treatment development.
Used in Antibacterial Applications:
Leveraging its antibacterial properties, 5,6-dichloro-1H-indazole is applied in the development of new antimicrobial agents to combat bacterial infections.
Used in Anti-inflammatory and Anticholinesterase Research:
5,6-Dichloro-1H-indazole is used as a research compound in studies focused on inflammation and cholinesterase inhibition, potentially leading to advancements in treatments for inflammatory diseases and neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 124691-76-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,6,9 and 1 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 124691-76:
(8*1)+(7*2)+(6*4)+(5*6)+(4*9)+(3*1)+(2*7)+(1*6)=135
135 % 10 = 5
So 124691-76-5 is a valid CAS Registry Number.
124691-76-5Relevant articles and documents
PYRROLOPYRAZINE KINASE INHIBITORS
-
, (2013/03/28)
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists
Shimada, Itsuro,Maeno, Kyoichi,Kazuta, Ken-ichi,Kubota, Hideki,Kimizuka, Tetsuya,Kimura, Yasuharu,Hatanaka, Ken-ichi,Naitou, Yuki,Wanibuchi, Fumikazu,Sakamoto, Shuichi,Tsukamoto, Shin-ichi
, p. 1966 - 1982 (2008/09/21)
A series of novel indazole derivatives were synthesized, and their structure-activity relationships examined in order to identify potent and selective 5-HT2C receptor agonists. Among these compounds, (S)-2-(7-ethyl-1H-furo[2,3-g]indazol-1-yl)-1-methylethylamine (YM348) had a good in vitro profile, that is, high agonistic activity to the human 5-HT2C receptor subtype (EC50 = 1.0 nM) and high selectivity over 5-HT2A receptors. This compound was also effective in a rat penile erection model when administered po.